GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (NSE:VALIANTLAB) » Definitions » Equity-to-Asset

Valiant Laboratories (NSE:VALIANTLAB) Equity-to-Asset : 0.00 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Valiant Laboratories's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₹0 Mil. Valiant Laboratories's Total Assets for the quarter that ended in Dec. 2024 was ₹0 Mil.

The historical rank and industry rank for Valiant Laboratories's Equity-to-Asset or its related term are showing as below:

NSE:VALIANTLAB' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.39   Med: 0.57   Max: 0.83
Current: 0.64

During the past 4 years, the highest Equity to Asset Ratio of Valiant Laboratories was 0.83. The lowest was 0.39. And the median was 0.57.

NSE:VALIANTLAB's Equity-to-Asset is ranked better than
56.43% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs NSE:VALIANTLAB: 0.64

Valiant Laboratories Equity-to-Asset Historical Data

The historical data trend for Valiant Laboratories's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valiant Laboratories Equity-to-Asset Chart

Valiant Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
0.83 0.39 0.47 0.69

Valiant Laboratories Quarterly Data
Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.69 - 0.64 -

Competitive Comparison of Valiant Laboratories's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Valiant Laboratories's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valiant Laboratories's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valiant Laboratories's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Valiant Laboratories's Equity-to-Asset falls into.


;
;

Valiant Laboratories Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Valiant Laboratories's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=2368.612/3426.873
=0.69

Valiant Laboratories's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=0/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valiant Laboratories  (NSE:VALIANTLAB) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Valiant Laboratories Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Valiant Laboratories Business Description

Traded in Other Exchanges
Address
Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines